MRC1 and neoplasm: During the study period, the routine laboratory diagnostic workup for simplex cases with an LS‐associated tumor diagnosed between ages 40–49 years included tumor tissue MMR protein immunohistochemical and mutation testing of BRAF, and subsequent targeted molecular genetic testing of any indicated MMR gene(s).